There is limited data available for adverse effects of casirivimab, but other adverse effects may come to light in the future. Adverse effects reported include:

- Hypersensitivity including anaphylaxis (8,000 mg dose)

- Infusion-related reactions included pyrexia, chills, abdominal pain, flushing, urticaria, and pruritus (8,000 mg dose)

- Nausea and Vomiting (2,400 mg dose)

Due to the possibility of hypersensitivity, including anaphylaxis and infusion-related reaction, observation in the infusion center is advised for at least one hour post-transfusion. Slow or stop the infusion and consider administering relevant medications and/or supportive care ifÂ there is a concern for an infusion-related reaction.